novo nordisk's semaglutide failed to slow alzheimer's disease progression Popular obesity drug fails in hotly anticipated trials | Science GLP-1RA Alzheimer's hopes dashed after

For more on which peptides are FDA-approved vs grey market-only, see our FDA approved peptides list 2026

Recognizing the characteristic uptake associated with GLP-1 agonists helps avoid unnecessary anxiety and interventions, ensuring patients receive the right care, at the right time, without detours or doubt, Strouhal said

Both have made a significant impact on weight management, but compounded tirzepatide stands out due to its unique benefits in helping patients lose weight effectively

Improvements in drug administration, including implantable devices, extended-release formulations, or non-invasive methods (like transdermal patches), may enhance patient satisfaction and broaden market appeal Impacted by recent drug approvals (for diverse applications) and substantial R&D investments from companies (to enhance delivery systems for GLP-1 drugs), the market is projected to witness steady growth in the coming decade